产品名称 | NebuSelect™ Recombinant Human MMP-8, His-tag |
---|---|
目录号 | NBL-242296 |
别名 | MMP-8; MMP-8; PMNL-CL; CLG1; MMP8; Collagenase 2; PMNL-CL; HNC |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P22894 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242296-100ug | 100ug | Inquire | Inquire | |
NBL-242296-1mg | 1mg | Inquire | Inquire | |
NBL-242296-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human MMP-8, His-tag
Catalog#:
NBL-242296
Description:
NebuSelect™ Recombinant Human MMP-8, His-tag(Cat#NBL-242296) is expressed in HEK293 with His tag at the C-Terminus. The protein needs to be activated by APMA to have hydrolytic activity.It contains Phe21-Gly467.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 52.2 kDa. Due to glycosylation, the protein migrates to 65-70 kDa based on Bis-Tris PAGE result.
Target Name:
MMP-8; MMP-8; PMNL-CL; CLG1; MMP8; Collagenase 2; PMNL-CL; HNC
Target Information:
Alteration of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) expression has been studied for various cardiac diseases, including dilated cardiomyopathy (DCM), with the significance of surrogate markers of extracellular matrix (ECM) remodeling. MMP-8 was identified only in myocardiocytes, while MMP-9 and TIMP-2 were present in both myocardiocytes and stroma, but with different intensity. The increasing intensity of MMP-8 and TIMP-2 immunoreactions was significantly associated with low HCS.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.